IN150 > (Ibandronate Sodium 150 mg (base))
Pill with imprint IN150 > is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc.
Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for IN150 >
Ibandronate Sodium
- Imprint
- IN150 >
- Strength
- 150 mg (base)
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
sorbitol,
microcrystalline cellulose,
silicon dioxide,
croscarmellose sodium,
sodium stearyl fumarate,
titanium dioxide,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3770 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 42291-0336 (Discontinued) | AvKare, Inc. |
Related images for "IN150 >"
More about ibandronate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (106)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: bisphosphonates
Patient resources
- Drug Information
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
- Ibandronate Tablets
- Ibandronate Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.